Peritoneal elimination of homocysteine moieties in continuous ambulatory peritoneal dialysis patients

Kidney International

Volumn 55, Issue 5, 1999, Pages 2054-2061

  Vychytil, Andreas ^a,b   Födinger, Manuela ^a,b   Papagiannopoulos, Menelaos ^a,b   Wölfl, Gabriele ^a,b   Hörl, Walter H ^a,b   Sunder Plassmann, Gere ^a,b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Klinisches Inst Med/Chemische L   (Austria)

Author keywords

CAPD; Cardiovascular disease; End stage renal disease; Hyperhomocysteinemia; Peritoneal transport

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; FEMALE; HUMAN; HYPERHOMOCYSTEINEMIA; KIDNEY FAILURE; MALE; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROTEIN TRANSPORT;

EID: 0032947759     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.00437.x     Document Type: Article

References (28)

1. 1. REFSUM H, UELAND PM, NYGÅRD O, VOLLSET SE: Homocysteine and cardiovascular disease. Annu Rev Med 49:31-62, 1998
2. 2. D'ANGELO A, SELHUB J: Homocysteine and thrombotic disease. Blood 90:1-11, 1997
3. 3. YEUN JY: The role of homocysteine in end-stage renal disease. Semin Dial 11:95-101, 1998
4. 4. BOSTOM AG, SHEMIN D, LAPANE KL, MILLER JW, SUTHERLAND P, NADEAU M, SEYOUM E, HARTMAN W, PRIOR R, WILSON PWF, SELHUB J: Hyperhomocysteinemia and traditional cardiovascular disease risk factors in end-stage renal disease patients on dialysis: A case-control study. Atherosclerosis 114:93-103, 1995
5. 5. ROBINSON K, GUPTA A, DENNIS V, ARHEART K, CHAUDHARY D, GREEN R, VIGO P, MAYER EL, SELHUB J, KUTNER M, JACOBSEN DW: Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations. Circulation 94:2743-2748, 1996
6. 6. CHAUVEAU P, CHADEFAUX B, COUDÉ M, AUPETIT J, HANNEDOUCHE T, KAMOUN P, JUNGERS P: Hyperhomocysteinemia, a risk factor for atherosclerosis in chronic uremic patients. Kidney Int 43(Suppl 41):S72-S77, 1993
7. 7. DENNIS VW, NURKO S, ROBINSON K: Hyperhomocysteinemia: Detection, risk assessment, and treatment. Curr Opin Nephrol Hypertens 6:483-488, 1997
8. 8. BOSTOM AG, LATHROP L: Hyperhomocysteinemia in end-stage renal disease: Prevalence, etiology, and potential relationship to arteriosclerotic outcomes. Kidney Int 52:10-20, 1997
9. 9. FÖDINGER M, MANNHALTER C, WÖLFL G, PABINGER I, MÜLLER E, SCHMID R, HÖRL WH, SUNDER-PLASSMANN G: Mutation (677 C to T) in the methylenetetrahydrofolate reductase gene aggravates hyperhomocysteinemia in hemodialysis patients. Kidney Int 52: 517-523, 1997
10. 10. VYCHYTIL A, FÖDINGER M, WÖLFL G, ENZENBERGER B, AUINGER M, PRISCHL F, BUXBAUM M, WIESHOLZER M, MANNHALTER C, HÖRL WH, SUNDER-PLASSMANN G: Major determinants of hyperhomocysteinemia in peritoneal dialysis patients. Kidney Int 53:1775-1782, 1998
11. 11. ROBINS AJ, MILEWCZYK BK, BOOTH EM, MALLICK NP: Plasma amino acid abnormalities in chronic renal failure. Clin Chim Acta 42:215-217, 1972
12. 12. KANG SS, WONG PWK, BIDANI A, MILANEZ S: Plasma protein-bound homocyst(e)ine in patients requiring chronic haemodialysis. Clin Sci 65:335-336, 1983
13. 13. LAIDLAW SA, SMOLIN LA, DAVIDSON WD, KOPPLE JD: Sulfur amino acids in maintenance hemodialysis patients. Kidney Int 32(Suppl 22):S191-S196, 1987
14. 14. HULTBERG B, ANDERSSON A, STERNER G: Plasma homocysteine in renal failure. Clin Nephrol 40:230-234, 1993
15. 15. TWARDOWSKI ZJ, NOLPH KD, KHANNA R, PROWANT BF, RYAN LP, MOORE HL, NIELSEN MP: Peritoneal equilibration test. Perit Dial Bull 7:138-147, 1987
16. 16. TWARDOWSKI ZJ: Clinical value of standardized equilibration tests in CAPD patients. Blood Purif 7:95-108, 1989
17. 17. ARAKI A, SAKO Y: Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr 422:43-52, 1987
18. 18. FROSST P, BLOM HJ, MILOS R, GOYETTE P, SHEPPARD CA, MATTHEWS RG, BOERS GJH, DEN HEIJER M, KLUIJTMANS LAJ, VAN DEN HEUVEL LP, ROZEN R: A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111-113, 1995
19. 19. ARNADOTTIR M, BRATTSTRÖM L, SIMONSEN O, THYSELL H, HULTBERG B, ANDERSSON A, NILSSON-EHLE P: The effect of high-dose pyridoxine and folic acid supplementation on serum lipid and plasma homocysteine concentrations in dialysis patients. Clin Nephrol 40:236-240, 1993
20. 20. BOSTOM AG, SHEMIN D, LAPANE KL, HUME AL, YOBURN D, NADEAU MR, BENDICH A, SELHUB J, ROSENBERG IH: High dose B-vitamin treatment of hyperhomocysteinemia in dialysis patients. Kidney Int 49:147-152, 1996
21. 21. VAN GULDENER C, JANSSEN MJFM, STEHOUWER CDA, JAKOBS C, BRONZWAER JGF, SURACHNO J, DONKER AJM: The effect of renal transplantation on hyperhomocysteinaemia in dialysis patients, and the estimation of renal homocysteine extraction in patients with normal renal function. Neth J Med 52:58-64, 1998
22. 22. FÖDINGER M, WÖLFL G, FISCHER G, RASOUL-ROCKENSCHAUB S, SCHMID R, HÖRL WH, SUNDER-PLASSMANN G: Effect of MTHFR 677C>T on plasma total homocysteine levels in renal graft recipients. Kidney Int 55:1072-1080, 1999
23. 23. BOSTOM AG, GOHH RY, TSAI MY, HOPKINS-GARCIA BJ, NADEAU MR, BIANCHI LA, JACQUES PF, ROSENBERG IH, SELHUB J: Excess prevalence of fasting and postmethionine-loading hyperhomocysteinemia in stable renal transplant recipients. Arterioscler Thromb Vasc Biol 17:1894-1900, 1997
24. 24. JANSSEN MJFM, VAN GULDENER C, DE JONG GMT, VAN DEN BERG M, STEHOUWER CDA, DONKER AJM: Folic acid treatment of hyperhomocysteinemia in dialysis patients. Miner Electrolyte Metab 22:110-114, 1996
25. 25. MUDD SH, POOLE JR: Labile methyl balances for normal humans on various dietary regimens. Metabolism 24:721-735, 1975
26. 26. GUTTORMSEN AB, UELAND PM, SVARSTAD E, REFSUM H: Kinetic basis of hyperhomocysteinemia in patients with chronic renal failure. Kidney Int 52:495-502, 1997
27. 27. NOLPH KD, MOORE HL, PROWANT B, TWARDOWSKI ZJ, KHANNA R, GAMBOA S, KESHAVIAH P: Continuous ambulatory peritoneal dialysis with a high flux membrane. ASAIO J 39:904-909, 1993
28. 28. SULIMAN ME, ANDERSTAM B, LINDHOLM B, BERGSTRÖM J: Total, free, and protein-bound sulphur amino acids in uraemic patients. Nephrol Dial Transplant 12:2332-2338, 1997